Luxbright
  • Products
    • Microfocus X-ray Tubes
    • Cold Cathode X-ray Sources
  • About
    • Our team
    • Quality Policy
    • Job Openings
  • News
  • Contact
  • Investor Relations
    • Företrädesemission 2023
    • EGM 24 januari 2023
    • Pressmeddelanden
    • Finansiella Rapporter
    • Finansiell Kalender
    • Bolagsstyrning
    • Aktien
    • IR Kontakt
    • Certified Advisor
    • Nomineringskommitté
    • Arkiv

KALLELSE TILL ÅRSSTÄMMA 2019 I LUXBRIGHTAB

27/5/2019

 
Aktieägarna  i  Luxbright  AB,  556910-9837,  kallas  till  årsstämma  den  10  juni  2019  kl.  17.00  i konferensrummet på plan 5 vid bolagets lokaler på Arvid Wallgrens Backe 20 i Göteborg.
RÄTT ATT DELTA OCH ANMÄLAN
Den  som  önskar  delta  på  stämman  ska  vara  införd  i  den  av  bolaget  förda  aktieboken  per dagen  för  stämman.  Aktieägare  uppmanas  att  anmäla  närvaro  (och  eventuella  biträden)  till bolaget    senast    den    6    juni    2019    till    bolagets    postadress    eller    via    e-post [email protected]   Vid   anmälan   bör   uppges   namn,   person-/organisationsnummer, adress, telefonnummer, registrerat aktieinnehav samt i förekommande fall uppgift om ombud och biträden.

Read More

NOTICE OF ANNUAL GENERAL MEETING 2019 IN LUXBRIGHT AB

27/5/2019

 
Shareholders of Luxbright AB, 556910-9837, are invited to attend the Annual General Meeting on June  10th,  2019  at  17:00  at  the Biotech  Center conference  room  on  level  5  located  at  the company's premises at Arvid Wallgrens Backe 20 in Gothenburg.
RIGHT TO PARTICIPATE AND REGISTRATION
Shareholders wishing to participate in the Annual General Meeting should be listed in the share register  kept  by  the  company  as  per  the  day  of  the  meeting.  Shareholders  are  encouraged  to notify  their  presence  (and  any  assistants)  to  the  company  by  June  6,  2019,  to  the  company's postal  address  or  via  e-mail [email protected]  The  notification  should  include  the  name, personal/organizational  number,  address,  telephone  number,  registered  shareholding  and,  if applicable, information on representatives and assistants should be stated.

Read More

    Categories

    All
    Icke Regulatoriskt
    Investor Relations
    Non Regulatory
    Other
    Regulatorisk

    Archives

    January 2023
    November 2022
    October 2022
    August 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    May 2020
    March 2020
    February 2020
    May 2019
    December 2018
    November 2018
    October 2018
    July 2018
    April 2018
    February 2018
    January 2018
    December 2017

About Luxbright

Luxbright offers X-ray emission solutions to international system suppliers. Our patented technology allows for world-leading image resolution and improved X-ray equipment to save, protect, and simplify people’s lives. Luxbright makes microfocus affordable and enables new applications based on cold cathode technology. Development, production, and testing are all carried out under the same roof in state-of-the-art facilities located in Gothenburg, Sweden.


quick links

Microfocus X-ray Tubes
Cold Cathode X-ray Sources
About Us
News
Investor Relations

Contact

Luxbright AB
Hulda Lindgrens gata 6b
421 31 Västra Frölunda
​Sweden
Tel: +46 31 796 06 97
Email: [email protected]


Legal Notice
Privacy Policy
Copyright © 2023 Luxbright AB
  • Products
    • Microfocus X-ray Tubes
    • Cold Cathode X-ray Sources
  • About
    • Our team
    • Quality Policy
    • Job Openings
  • News
  • Contact
  • Investor Relations
    • Företrädesemission 2023
    • EGM 24 januari 2023
    • Pressmeddelanden
    • Finansiella Rapporter
    • Finansiell Kalender
    • Bolagsstyrning
    • Aktien
    • IR Kontakt
    • Certified Advisor
    • Nomineringskommitté
    • Arkiv